Increase in Independent License Holder Option in India
More companies are setting up a subsidiary or using an independent license holder in order navigate the highly rationalized Indian market.
If you are not happy with the results below please do another search
More companies are setting up a subsidiary or using an independent license holder in order navigate the highly rationalized Indian market.
The Drugs Controller General of India (DCGI) announced on May 1, 2016 that the SUGAM online application submission system, in use since November 2015 for pharmaceutical registration, would be extended to medical device and IVD device submissions (e.g., registration and import license applications).
Japan should be the second largest national market for your medical device after the United States and maximizing sales performance in Japan should be critical to your overall corporate success. Yet, many manufacturers are frustrated by their results in Japan or struggle to attract the interest of leading distributors. Follow these steps to create a winning market strategy in Japan that will wow investors and leapfrog the competition.